s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Thursday, February 25, 2021
Accession number
0001493152-21-004771
Documents
form8-k.htm
425
On sec.gov
Filing index
All files
Complete submission text
SGML header